Incannex Healthcare Inc. (Australia)

Homepage: incannex.com

Alternate names: Incannex, Incannex Healthcare, Incannex Healthcare Inc., Incannex Healthcare Limited

ROR: 03q5ss215

OpenAlex ID: I4405267642

Fungal Extracellular Vesicles in Pathophysiology

2021 · Donovan Garcia-Ceron, Mark R. Bleackley, et al. · Sub-cellular biochemistry/Subcellular biochemistry · 12

The impact of acetazolamide and dronabinol on the physiological endotypes responsible for obstructive sleep apnea

2025 · Luke D.J. Thomson, Shane A. Landry, et al. · Sleep Medicine · 9

A randomized dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnea

2024 · Jennifer Walsh, Timothy Rankin, et al. · SLEEP · 9

An open-label phase I comparator-controlled clinical trial to assess tolerability and pharmacokinetics of IHL-675 A a fixed dose combination of cannabidiol plus hydroxychloroquine in healthy volunteers

2025 · George Williams Mbogo, Pia Kroner, et al. · Scientific Reports · 3

0451 Dronabinol Plus Acetazolamide for the Treatment of Obstructive Sleep Apnoea: A Proof of Concept and Mechanistic Exploration Study

2023 · Luke Thomson, Timothy Rankin, et al. · SLEEP · 1

A Randomized Four-Period Cross-Over Phase I Study to Assess Bioavailability, Bioequivalence, and Tolerability of IHL-42X Compared with the Reference Drugs in Healthy Volunteers

2026 · George Williams Mbogo, Amanda Sallama, et al. · Clinical Drug Investigation

A Randomised Controlled Trial Examining the Combined Impact of Acetazolamide and Dronabinol for the Treatment of Obstructive Sleep Apnoea

2023 · L.D.J. Thomson, T. Rankin, et al. · American Journal of Respiratory and Critical Care Medicine

O027 A randomised dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnoea: A proof of concept study

2022 · J Walsh, T Rankin, et al. · SLEEP Advances

Works count: 8

Citation count: 62